Literature DB >> 22195768

Modified plastic compression of collagen hydrogels provides an ideal matrix for clinically applicable skin substitutes.

Erik Braziulis1, Mirco Diezi, Thomas Biedermann, Luca Pontiggia, Marlene Schmucki, Fabienne Hartmann-Fritsch, Joachim Luginbühl, Clemens Schiestl, Martin Meuli, Ernst Reichmann.   

Abstract

Tissue engineering of clinically applicable dermo-epidermal skin substitutes is crucially dependent on the three-dimensional extracellular matrix, supporting the biological function of epidermal and dermal cells. This matrix essentially determines the mechanical stability of these substitutes to allow for safe and convenient surgical handling. Collagen type I hydrogels yield excellent biological functionality, but their mechanical weakness and their tendency to contract and degrade does not allow producing clinically applicable transplants of larger sizes. We show here that plastically compressed collagen type I hydrogels can be produced in clinically relevant sizes (7×7 cm), and can be safely and conveniently handled by the surgeon. Most importantly, these dermo-epidermal skin substitutes mature into a near normal skin that can successfully reconstitute full-thickness skin defects in an animal model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22195768     DOI: 10.1089/ten.TEC.2011.0561

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  33 in total

1.  Experimental tissue engineering of fetal skin.

Authors:  L Mazzone; L Pontiggia; E Reichmann; N Ochsenbein-Kölble; U Moehrlen; M Meuli
Journal:  Pediatr Surg Int       Date:  2014-10-22       Impact factor: 1.827

2.  Rapid Fabrication of Living Tissue Models by Collagen Plastic Compression: Understanding Three-Dimensional Cell Matrix Repair In Vitro.

Authors:  Umber Cheema; Robert A Brown
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-05       Impact factor: 4.730

3.  De novo epidermal regeneration using human eccrine sweat gland cells: higher competence of secretory over absorptive cells.

Authors:  Luca Pontiggia; Thomas Biedermann; Sophie Böttcher-Haberzeth; Carol Oliveira; Erik Braziulis; Agnieszka S Klar; Claudia Meuli-Simmen; Martin Meuli; Ernst Reichmann
Journal:  J Invest Dermatol       Date:  2014-01-21       Impact factor: 8.551

4.  The influence of stromal cells on the pigmentation of tissue-engineered dermo-epidermal skin grafts.

Authors:  Thomas Biedermann; Sophie Böttcher-Haberzeth; Agnieszka S Klar; Daniel S Widmer; Luca Pontiggia; Andreas D Weber; Daniel M Weber; Clemens Schiestl; Martin Meuli; Ernst Reichmann
Journal:  Tissue Eng Part A       Date:  2015-01-07       Impact factor: 3.845

5.  Successful grafting of tissue-engineered fetal skin.

Authors:  L Mazzone; M Pratsinis; L Pontiggia; E Reichmann; M Meuli
Journal:  Pediatr Surg Int       Date:  2016-09-20       Impact factor: 1.827

6.  Design and biofabrication of dermal regeneration scaffolds: role of oligomeric collagen fibril density and architecture.

Authors:  David O Sohutskay; Kevin P Buno; Sunil S Tholpady; Samantha J Nier; Sherry L Voytik-Harbin
Journal:  Regen Med       Date:  2020-03-31       Impact factor: 3.806

7.  A Biomimetic Collagen-Apatite Scaffold with a Multi-Level Lamellar Structure for Bone Tissue Engineering.

Authors:  Z Xia; M M Villa; M Wei
Journal:  J Mater Chem B       Date:  2014-04-14       Impact factor: 6.331

8.  Analysis of blood and lymph vascularization patterns in tissue-engineered human dermo-epidermal skin analogs of different pigmentation.

Authors:  Agnieszka S Klar; Sophie Böttcher-Haberzeth; Thomas Biedermann; Clemens Schiestl; Ernst Reichmann; Martin Meuli
Journal:  Pediatr Surg Int       Date:  2014-02       Impact factor: 1.827

9.  A new model for preclinical testing of dermal substitutes for human skin reconstruction.

Authors:  Fabienne Hartmann-Fritsch; Thomas Biedermann; Erik Braziulis; Martin Meuli; Ernst Reichmann
Journal:  Pediatr Surg Int       Date:  2013-02-01       Impact factor: 1.827

10.  Optimizing in vitro culture conditions leads to a significantly shorter production time of human dermo-epidermal skin substitutes.

Authors:  Luca Pontiggia; Agnieszka Klar; Sophie Böttcher-Haberzeth; Thomas Biedermann; Martin Meuli; Ernst Reichmann
Journal:  Pediatr Surg Int       Date:  2013-02-03       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.